1. Home
  2. NXPL vs CING Comparison

NXPL vs CING Comparison

Compare NXPL & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPL
  • CING
  • Stock Information
  • Founded
  • NXPL 1997
  • CING 2012
  • Country
  • NXPL United States
  • CING United States
  • Employees
  • NXPL N/A
  • CING N/A
  • Industry
  • NXPL Telecommunications Equipment
  • CING Biotechnology: Pharmaceutical Preparations
  • Sector
  • NXPL Telecommunications
  • CING Health Care
  • Exchange
  • NXPL Nasdaq
  • CING Nasdaq
  • Market Cap
  • NXPL 17.9M
  • CING 17.3M
  • IPO Year
  • NXPL N/A
  • CING 2021
  • Fundamental
  • Price
  • NXPL $0.76
  • CING $5.50
  • Analyst Decision
  • NXPL
  • CING Strong Buy
  • Analyst Count
  • NXPL 0
  • CING 4
  • Target Price
  • NXPL N/A
  • CING $30.67
  • AVG Volume (30 Days)
  • NXPL 62.7K
  • CING 104.9K
  • Earning Date
  • NXPL 08-13-2025
  • CING 08-12-2025
  • Dividend Yield
  • NXPL N/A
  • CING N/A
  • EPS Growth
  • NXPL N/A
  • CING N/A
  • EPS
  • NXPL N/A
  • CING N/A
  • Revenue
  • NXPL $62,515,000.00
  • CING N/A
  • Revenue This Year
  • NXPL N/A
  • CING N/A
  • Revenue Next Year
  • NXPL N/A
  • CING N/A
  • P/E Ratio
  • NXPL N/A
  • CING N/A
  • Revenue Growth
  • NXPL 19.36
  • CING N/A
  • 52 Week Low
  • NXPL $0.43
  • CING $1.80
  • 52 Week High
  • NXPL $2.30
  • CING $20.83
  • Technical
  • Relative Strength Index (RSI)
  • NXPL 49.77
  • CING 66.64
  • Support Level
  • NXPL $0.75
  • CING $4.25
  • Resistance Level
  • NXPL $0.94
  • CING $6.01
  • Average True Range (ATR)
  • NXPL 0.07
  • CING 0.34
  • MACD
  • NXPL -0.00
  • CING 0.09
  • Stochastic Oscillator
  • NXPL 18.18
  • CING 71.02

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: